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Abstract
Background: Dyslipidemia is a well-known risk factor for cardiovascular disease (CVD). Recently, atherogenic index
of plasma (AIP) has been proposed as a novel predictive marker for CVD, and few cross sectional studies have
demonstrated a relationship between AIP and coronary artery disease. The present study investigated the
association between AIP and the progression of coronary artery calcification (CAC) in Korean adults without CVD.
Methods: A total of 1124 participants who had undergone CAC measurement at least twice by multi-detector
computed tomography (CT) at a health check-up center were enrolled. Their anthropometric measurements and
various cardiovascular risk factors were assessed. AIP was defined as the base 10 logarithm of the ratio of the
concentration of triglyceride (TG) to high-density lipoprotein-cholesterol (HDL-C). CAC progression was defined as
either incident CAC in a CAC-free population at baseline, or an increase of ≥2.5 units between the square roots of
the baseline and follow-up coronary artery calcium scores (CACS) in subjects with detectable CAC at baseline.
Results: CAC progression was observed in 290 subjects (25.8%) during the mean follow-up of 4.2 years. All subjects
were stratified into three groups according to AIP. There were significant differences in cardiovascular parameters
among groups at baseline. The follow-up CAC and the incidence of CAC progression increased gradually with rising
AIP tertiles. In logistic regression analysis, the odds ratio for CAC progression was 2.27 when comparing the highest
to the lowest tertile of AIP (95% CI: 1.61–3.19; P for trend < 0.01). However, this association was attenuated after
adjustment for multiple risk factors (P for trend = 0.67).
Conclusions: There is a significant correlation between AIP and the progression of CAC in subjects without CVD.
Although AIP was not an independent predictor of CAC progression, AIP should be considered when estimating
the current as well as future CVD risk, along with other traditional risk factors.
Keywords: Atherogenic index of plasma, Coronary artery calcification progression, Coronary artery calcification
score, Atherosclerosis, Cardiac computed tomography, Cardiovascular risk factor
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Background
Cardiovascular disease (CVD) is the leading cause of
morbidity and mortality worldwide. Coronary artery cal-
cification (CAC), as determined by multi-detector com-
puted tomography (CT), is a sensitive measure to detect
the existence of early coronary atherosclerosis. More-
over, CAC is considered an important risk factor for car-
diovascular events [1–3]. Dyslipidemia is one of the
most important factors that contribute to CVD. The as-
sociation between CVD and the traditional lipid mea-
sures, including total cholesterol (TC), low-density
lipoprotein cholesterol (LDL-C), triglyceride (TG), high-
density lipoprotein cholesterol (HDL-C), and Lipopro-
tein (a), has been well-demonstrated [4].
Recently, the atherogenic index of plasma (AIP), a
logarithmically transformed ratio of molar concentra-
tions of TG to HDL-C, has been suggested as a novel
marker for atherosclerosis and CVD [5–7]. Elevated TG
and a low HDL level are strong markers of cardiovascu-
lar diseases, and an increase of TG levels causes an in-
crease in the small dense LDL level and ultimately
increases CV risk [8]. Some studies have reported its su-
periority in predicting atherosclerosis compared to trad-
itional lipid parameters [7, 8]. For example, in a large
cohort study consisting of postmenopausal women
undergoing coronary angiography, Guo et al. demon-
strated AIP to be superior to traditional lipid indices for
predicting coronary artery disease in univariate as well
as multivariate regression analysis [9].
Most of the previous studies compared the AIP be-
tween patients with overt coronary artery disease (CAD)
and controls, and showed inconsistent results, while
some prior studies assessed the correlations between
AIP and traditional CVD risk factors, including Framing-
ham risk score [10–12]. To date, no existing study has
investigated the relationship between AIP and early
coronary atherosclerosis in relatively low-risk subjects
without CVD. Furthermore, while CAC progression has
been suggested to be a stronger predictor of CVD mor-
tality compared to baseline coronary artery calcification
score (CACS) or traditional cardiovascular risk factors
[13], there is a lack of data on the relationship between
AIP and CAC progression. Therefore, the present study
aimed to investigate the relationship between AIP and




The present study was a retrospective longitudinal study.
The study subjects comprised of 9581 Korean adults
who underwent cardiac CT examination at Gangnam
Severance Hospital Health Promotion Center in Seoul,
Korea between July 2006 and April 2018. Initially, 1329
individuals who had undergone at least two cardiac CT
scans were enrolled. Then, subjects with any malignancy,
renal disease, acute inflammatory disease, missing data
or a history of previous cerebrovascular event, myocar-
dial infarction, or angina were excluded. Patients taking
lipid-lowering medication were also excluded. Finally,
1124 subjects were analyzed (Fig. 1). This study was
approved by the Institutional Review Board of Yonsei
University College of Medicine (IRB approval number:
3–2019-0190).
Anthropometric measurement and laboratory assessment
Subjects were examined after 12 h of fasting. They wore
light clothing without shoes during body weight mea-
surements. Body mass index (BMI) was determined
using the following formula: body weight (in kg) divided
by the square of person’s height (in meters). Measure-
ments of systolic blood pressure (SBP) and diastolic
Fig. 1 Flow chart of the study subjects
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blood pressure (DBP) were taken by trained nurses using
an automatic blood pressure monitor (HEM-7080IC;
Omron Healthcare, Lake Forest, IL, USA).
Blood sampling was performed for biochemical assess-
ments including triglyceride (TG), total cholesterol (TC),
high-density lipoprotein cholesterol (HDL-C), and fast-
ing plasma glucose (FPG) using Hitachi 7600–120
automated chemistry analyzer (Hitachi, Tokyo, Japan).
The calculation of low-density lipoprotein cholesterol
(LDL-C) was done using the Friedewald formula. AIP
was defined as the base 10 logarithm of the ratio of the
concentration of TG to HDL-C, and each concentration
was expressed in mmol/L [7].
Data on the subjects’ lifestyle habits, personal medical
information, and medication history were collected
through a questionnaire. A subject was considered to be
a current smoker, if he/she smoked regularly in the last
6 months. A subject who consumed alcoholic beverages
more than three times a week was considered to be a
current drinker. Exercise with a moderate intensity for
more than half an hour, at least three times a week, was
defined as regular exercise. A subject was considered
diabetic based on his/her previous history of diabetes,
current use of antidiabetic medications, or the American
Diabetes Association diagnostic criteria. SBP or DBP of
greater than or equal to 140/90 mmHg and/or antihyper-
tensive medication usage were considered as the criteria
for hypertension.
CAC assessment
CAC measurement was performed with a multi-detector
CT scanner (Phillips Brilliance 64; Philips Medical Sys-
tem, Best, The Netherlands) using a prospective
electrocardiogram-gating protocol with a step-and-shoot
technique [14]. All subjects were in the supine position,
and held their breath during the imaging process. One
of the three trained radiologists, who were all blinded to
the laboratory and clinical information, performed the
analysis of coronary CT images. CACS was quantified
automatically with dedicated software, and the severity
was assessed using the Agatston score (Aquarius Work-
station, TeraRecon, Inc., San Mateo, CA). A CACS
above 0 was defined as coronary artery calcification.
CAC progression was defined as either (A) incident
CAC, indicating a baseline Agatston score of 0 but
detectable CAC at follow-up examination in a popula-
tion free from CAC at baseline [15], or (B) an in-
crease of ≥2.5 units between baseline and final square
root of CACS in participants with detectable CAC at
baseline [16].
Statistical analysis
Continuous variables are shown as the mean ± SD.,
whereas continuous variables with skewed distributions
were expressed as the median with interquartile range.
Chi square tests were performed to compare categorical
variables, expressed as percentages. Analysis of variance
was used for between-group analyses. The association
between CAC progression and AIP was assessed by
multiple logistic regression, after adjustment for any
potential confounders. In the multivariate model, the
following covariates were chosen due to their clinical
importance and statistical significance in the univariate
analysis: age, sex, BMI, SBP, LDL-C, exercise, alcohol,
smoking, presence of diabetes or hypertension, and base-
line Ln (CACS+ 1). Statistical analyses were performed
using SPSS 25.0 (SPSS, Inc., Chicago, IL, USA), and P <
0.05 was considered statistically significant.
Results
Baseline characteristics
A total 1124 subjects were analyzed in this study. Table 1
shows the clinical and biochemical characteristics of the
study participants. The subjects were stratified into three
groups of T1, T2, and T3, with T1 being the lowest base-
line AIP tertile and T3 being the highest tertile. Significant
differences were observed in metabolic parameters among
groups. SBP, DBP, BMI, as well as serum FPG, TC, TG,
and LDL-C levels increased and HDL-C level decreased in
the order of increasing AIP tertile. In addition, the highest
AIP group had the greatest number of subjects with
hypertension, diabetes, and current smoking habits. Alco-
hol intake and exercise habits were not significantly differ-
ent between groups. Baseline CACS gradually increased
with the increasing order of AIP tertile.
Follow-up CACS
Table 2 shows the follow-up CACS and related parame-
ters according to baseline AIP. The average follow-up
period was 4.2 ± 2.2 years, and it was not significantly
different among groups. Follow-up CACS and the inci-
dence of CAC progression significantly increased in the
order of increasing AIP tertile.
Figure 2 demonstrates that both the Δ √transformed
CACS (T1, 0.90 ± 2.40; T2, 1.47 ± 3.42; T3, 2.01 ± 3.61;
P < 0.01) and annualized Δ √transformed CACS (T1,
0.20 ± 0.70; T2, 0.36 ± 1.31; T3, 0.45 ± 0.81; P < 0.01)
values increased across the tertiles of AIP at baseline.
The group with the higher baseline AIP had the greater
Δ √transformed CACS and also the annualized Δ √trans-
formed CACS values.
Association between CAC progression and AIP
The relationship between AIP and the progression of
CAC was explored by categorizing the baseline AIP into
tertiles, using the first tertile as the reference (Table 3,
Supplementary Table 1). An unadjusted multiple logistic
regression analysis revealed that, with T1 as the
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reference, the AIP levels for T2 and T3 increased the
ORs for CAC progression. This relationship remained
statistically significant after adjustment for sex and age.
However, this association was attenuated after additional
adjustments for BMI, SBP, FPG, LDL-C, exercise, alco-
hol, smoking, presence of diabetes and hypertension,
and baseline Ln (CACS+ 1).
Discussion
The present study showed a significant relationship be-
tween AIP and CAC, as well as the progression of CAC,
over a 4-year period in Korean adults without CVD.
These findings were consistent with previous studies
that showed strong associations between AIP and car-
diovascular risk factors and CVD. Furthermore, to the
best of our knowledge, this study was the first to reveal
a longitudinal association between AIP and CAC
progression.
Table 1 Baseline characteristics of participants according to AIP tertiles
T1 T2 T3 P value
N 376 373 375
Age (years) 51.4± 8.0 52.0± 7.4 51.3±7.7 0.43
Sex (M/F) 182/194 281/92 331/44
SBP (mmHg) 120.5±16.6 123.4±15.6 126.6±14.5 <0.01
DBP (mmHg) 74.8±10.5 77.6±9.6 80.1±8.7 <0.01
BMI (kg/m2) 22.9±2.8 24.1±2.7 25.4±2.8 <0.01
FPG (mmol/L) 5.08±0.80 5.40±0.80 5.67±1.11 <0.01
TC (mmol/L) 5.00±0.83 5.09±0.92 5.25±0.99 <0.01
TG (mmol/L) 0.75±0.18 1.21±0.26 2.17±0.67 <0.01
HDL-C (mmol/L) 1.60±0.29 1.28±0.22 1.06±0.2 <0.01
LDL-C (mmol/L) 3.04±0.76 3.3±0.82 3.37±0.89 <0.01
AIP -0.31(-0.41, -0.24) -0.03(-0.09, 0.04) 0.27(0.18, 0.39) <0.01
HTN (%) 68(18.1) 102(27.3) 114(30.5) <0.01
DM (%) 17(4.5) 27(7.2) 37(12.6) <0.01
Alcohol (%) 46(12.2) 62(16.6) 64(17.1) 0.12
Smoking (%) 19(5.1) 44(11.8) 59(15.8) <0.01
Exercise (%) 63(16.8) 73(19.6) 52(13.9) 0.12
Baseline CACS 13.3±46.9 23.8±79.1 25.8±90.3 <0.05
Categorical CACS <0.01
0 289(76.9) 265 (71.0) 260 (69.3)
0< and ≤10 23 (6.1) 29 (7.8) 26 (6.9)
>10 64(17.0) 79(21.2) 89 (23.8)
Baseline Ln (CACS+1) 0.75±1.53 1.02±1.78 1.03±1.77 0.03
CAC > 0 (%) 87 (23.1) 108 (29.0) 117 (31.2) <0.05
Data are mean ± SD, number (percentage), or median (interquartile range)
Statistical significances were tested by Oneway analysis of variances among groups
SBP systolic blood pressure, DBP diastolic blood pressure, FPG fasting plasma glucose, TC total cholesterol, TG triglyceride, AIP atherogenic index of plasma, HTN
hypertension, DM diabetes mellitus, Alcohol moderate drinking, Smoking current smoker, Exercise regular exercise of moderate intensity, CACS coronary artery
calcium score
Table 2 Follow-up CAC-related parameters according to
baseline AIP tertiles
T1 T2 T3 P value
N 376 373 375
Follow-up CACS 27.8±83.5 53.3±162.7 64.0±191.6 <0.01
Categorical CACS <0.01
0 271 (72.1) 223 (59.8) 208 (55.5)
<0 and≤10 14 (3.7) 27 (7.2) 29 (7.7)
>10 91 (24.2) 123 (33.0) 138 (36.8)
Follow-up Ln (CACS+1) 1.07±1.88 1.54±2.12 1.77±2.19 <0.01
Observation time (years) 4.1±2.2 4.2±2.3 4.3±2.2 0.32
CAC progression (%) 66 (17.6) 102 (27.3) 122 (32.5) <0.01
Data are mean ± SD, number (percentage)
Statistical significances were tested by Oneway analysis of variances
among groups
CACS coronary artery calcium score, AIP atherogenic index of plasma
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When the study subjects were categorized into tertiles
according to AIP, those at the highest tertile had the
highest BP, BMI, CACS, and adverse lipid profiles. Also,
the incidence of diabetes, hypertension, alcohol drinking,
and smoking were the highest in this group. In line with
the results of the present study, prior studies demon-
strated that AIP is an independent predictor of CAD
among Chinese subjects, Chinese postmenopausal
women, and very young adults [10, 11, 17]. Another re-
cent study revealed that AIP predicts a plaque burden in
intermediate CVD risk patients presenting with chest
pain [18]. In addition, AIP was associated with various
metabolic disorders, including fatty liver disease, hyper-
tension, diabetes, and diabetic complications [19, 20].
While most of these studies were conducted on subjects
with overt CAD or chest pain, or those diagnosed with
diabetes, which is considered equivalent to CAD, this
study excluded subjects with CAD or cerebrovascular
disease, as well those undergoing lipid-lowering therapy.
Despite the relatively low cardiovascular risk of the study
population, higher AIP was still associated with higher
CACS.
Furthermore, higher AIP was associated with the pro-
gression of CAC. While 17.6% of the subjects in the low-
est AIP tertile showed CAC progression, 32.5% of the
subjects in the highest tertile showed CAC progression.
Moreover, the Δ √transformed CACS and the annual Δ
√transformed CACS increased gradually across the ter-
tile, indicating that the baseline AIP predicts the pro-
gression of CAD and possibly future coronary events.
Similar results were obtained when subjects were di-
vided into low risk and high risk CVD groups according
to AIP values. Those with AIP value of under 0.11
belonged in low risk group and those with AIP values
higher than 0.21 in high risk group. There was a signifi-
cant difference in follow-up CACS between low risk and
high risk groups (40.6 ± 129.4 vs. 73.3 ± 220.2, P = 0.026),
and high risk group showed a higher percentage or CAC
progression compared to low risk group (22.6 vs. 32.9%,
P = 0.03).
However, after adjusting for various conventional car-
diovascular risk factors, such as blood pressure, glucose,
LDL-C, exercise, alcohol, smoking, BMI, and the pres-
ence of hypertension and diabetes, the predictive value
of AIP on CAC progression lost its significance. There
are several possible reasons for this, including a near
normal, narrow range of lipid parameters of subjects in
the current study. Even the subjects in the highest tertile
AIP had the mean TG level of 2.17 mmol/L and mean
HDL-C level of 1.06 mmol/L. Previous studies showed
that high TG and low HDL-C were closely associated
Fig. 2 The change in coronary artery calcification according to AIP tertile Δ √transformed CACS and annualized Δ √transformed CACS values
increased across the tertiles of AIP at baseline (T1: lowest AIP tertile, T2: second AIP tertile, T3: highest AIP tertile)
Table 3 Odds ratios and 95% confidence intervals for CAC
progression according to AIP tertiles
OR (95% CI) P for
trendT1 T2 T3
AIP
Model 1 1.00 1.77 (1.25-2.51) 2.27 (1.61-3.19) <0.01
Model 2 1.00 1.37 (0.94-1.99) 1.65 (1.14-2.39) 0.03
Model 3 1.00 1.13 (0.75-1.70) 1.21 (0.80-1.85) 0.67
Model 1: Unadjusted
Model 2: Adjusted for age and sex
Model 3: Model 2 + BMI, SBP, FPG, LDL-C, exercise, alcohol, smoking, presence
of diabetes and hypertension, and baseline Ln (CACS+1)
BMI body mass index, SBP systolic blood pressure, DBP diastolic blood
pressure, FPG fasting plasma glucose, LDL-C low density lipoprotein
cholesterol, CACS coronary artery calcium score
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with CAC, even more than LDL-C [21, 22]. If the range
of AIP in this study was wider with more extreme
values, it may have resulted in a significant relationship.
Also, while AIP is an independent risk factor for CAD in
a cross-sectional setting [10, 11], other factors may be
more critical to the progression of CAD. For example,
insulin resistance is an important risk factor for athero-
sclerosis [23], and our previous study also demonstrated
that triglyceride-glucose (TyG) index, which is a surro-
gate marker of insulin resistance, is an independent pre-
dictor of CAC progression [24]. Although AIP has been
reported to be related with insulin resistance in Type 2
diabetes patients, its relationship has been somewhat in-
consistent [25, 26]. In addition, some genetic risk
scores based one known GWAS SNPs associated with
CVD and CVD risk factors have been studied, and
genetic determinants were shown to influence the
progression of CAC [27]. Also, although it was not
assessed in this study, calcium regulatory mechanisms
that affect bone formation and growth are also known
to influence CAC [28].
Although AIP did not predict the progression of CAC,
it does not imply that AIP is not a good predictor of
CVD. Recently, there has been a controversy over the
prognostic value of the repeated measure of CAC in pre-
dicting CVD [29]. While prior studies suggested the
additive contribution of changes in CAC in the predic-
tion of CV, other studies showed that CAC change was
only the fifth strongest risk marker for CHD, following
baseline CAC, gender, SBP, and total cholesterol [30].
Also, MESA demonstrated that a CAC change of greater
than > 100 U/y was associated with coronary heart dis-
ease, independent of risk factors and baseline CAC score
[30]. In other words, although AIP was not able to inde-
pendently predict the progression of AIP, it does not
mean that is a good predictive marker of future CVD,
and that it may have a synergistic role with the baseline
CACS.
Study strengths and limitation
The strength of the current study lies on the fact that it
was the first study to investigate a longitudinal associ-
ation between AIP and CAC progression. While most of
the previous studies were conducted on subjects with
CVD, our participants were with a relatively low CV risk,
without prior CVD history. Meanwhile, there are several
limitations. First, since this was a retrospective, longitu-
dinal study, not all of the potential confounding factors
were controlled. For example, although subjects taking
lipid lowering drugs were excluded, those on antiplatelet
agents and anti-diabetic, anti-hypertensive drugs that
could affect the progression of atherosclerosis and AIP
were included. Since the medication history was based
on a questionnaire, the information on dose and class of
these drugs were not available, and therefore these ef-
fects were not considered in the analysis. Also, diet, ex-
ercise, smoking, and alcohol consumption patterns were
not controlled or monitored during the follow-up
period, which was variable. Second, the results of this
study cannot be generalized. People with existing CAD
as well as those with no CVD risk were unlikely to be in-
cluded in the current study, which led to nearly normal
plasma lipid levels and a narrow range of CACS. More-
over, this study only included subjects who voluntarily
took repeated coronary CT scans for a health check-up,
which could lead to a selection bias. In addition, the sex
ratio of the study participants was skewed especially in
AIP tertiles 2 and 3. However, a subgroup analysis on
gender was not conducted due to a limited number of
study subjects. Last, this study used the same definition
of CAC progression as a previous paper [23], but there
is no consensus on the optimal way to quantify CAC
change.
Conclusion
Recently, AIP has been suggested as a novel marker for
atherosclerosis and CVD, and some studies have demon-
strated its prognostic value to be superior compared to
traditional lipid parameters. Despite aforementioned
limitations, this study offers significant implications that
are clinically relevant, as it is the first to investigate the
association between AIP and CAC progression. In this
study of Korean subjects without CAD, subjects with
higher AIP had an increased risk for cardiovascular dis-
ease and higher CACS, and were more prone to CAC
progression over a 4-year period. Although AIP was not
an independent predictor of CAC progression, a well-
controlled prospective study including subjects with and
without CVD is warranted in the future to further con-
firm the prognostic value of AIP. Until then, AIP should
be considered when estimating the current as well as fu-
ture CVD risk, along with other traditional risk factors.
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